Persistent Fetal Circulation Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases
|
Disease or Syndrome
|
14
|
7
|
0.210 |
None |
1.000 |
11 |
|
2000 |
2018 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.500 |
None |
1.000 |
11 |
|
2001 |
2017 |
Pre-Eclampsia
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
166
|
14
|
0.680 |
None |
1.000 |
9 |
|
2001 |
2017 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
8 |
|
2001 |
2012 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.360 |
None |
1.000 |
8 |
|
2004 |
2009 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
8 |
|
2001 |
2012 |
Retinal Diseases
|
group |
Eye Diseases
|
Disease or Syndrome
|
714
|
56
|
0.080 |
None |
0.875 |
8 |
|
1999 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2020 |
Cardiomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
267
|
11
|
0.510 |
None |
1.000 |
6 |
|
2001 |
2018 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.500 |
None |
1.000 |
6 |
|
2001 |
2017 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.350 |
None |
1.000 |
6 |
|
2002 |
2011 |
Hyperlipidemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
472
|
83
|
0.530 |
None |
1.000 |
5 |
|
2001 |
2018 |
Portal Hypertension
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
167
|
9
|
0.510 |
None |
1.000 |
5 |
|
2000 |
2017 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.500 |
None |
1.000 |
5 |
|
2006 |
2018 |
Myocardial Reperfusion Injury
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
226
|
|
0.500 |
None |
1.000 |
5 |
|
2002 |
2018 |
Cerebrovascular Disorders
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
233
|
56
|
0.050 |
None |
1.000 |
5 |
|
2000 |
2018 |
Diabetic Angiopathies
|
disease |
Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
106
|
7
|
0.520 |
None |
1.000 |
5 |
|
2002 |
2017 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
4 |
|
2001 |
2009 |
Limb ischemia
|
disease |
|
Disease or Syndrome
|
171
|
3
|
0.220 |
None |
1.000 |
4 |
|
2006 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2019 |
Glaucoma
|
disease |
Eye Diseases
|
Disease or Syndrome
|
770
|
198
|
0.040 |
None |
0.750 |
4 |
|
2005 |
2018 |
Lupus Nephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
503
|
64
|
0.040 |
None |
1.000 |
4 |
|
2004 |
2012 |
Middle Cerebral Artery Occlusion
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Acquired Abnormality
|
626
|
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2019 |
Kidney Failure
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
378
|
36
|
0.040 |
None |
0.750 |
4 |
|
1998 |
2012 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
4 |
|
2001 |
2006 |